Abstract:Background:Bone marrow-derived mesenchymal stem cells (MSCs) have been proved in vitro to inducible differentiate into many kinds of cells of mesenchymal tissues such as osteocytes,chondrocytes, adipocytes,myocytes et al,especially myocardium cells. Recently it was shown that the wall thickness and heart function were improved after MSCs implantation in animal experiments and large-scale clinical trials. But other studies didn’t show that grafted stem cells can bring benefits to heart function in patients with cardiac disease. These therapeutic differences may be rise at least because of lack of visible method to trace in vivo grafted stem cells bio-behaviors such as survive,proliferation,distribution and differentiation. In recent decade an in vivo cellular tracking techniques by using luciferase marker so called BLU have been developed for long-term study of stem cells homing and migration. Bioluminescent imaging ( BLU) technology is a technology to integrate exogenous report luciferase genes into host cells,and express luciferase. This enzyme will give out the visible light when it reacts with its substrate fluorescein under the condition of existing O2 and ATP,to track living cells in real time. In BLU technology the vector for gene transfection is considered a principal because it very closely links to gene transfection efficiency and hence cells lumination. Objective:By using reconstructed-lentivirus vector transfection and bioluminescent imaging techniques to monitor in vivo survival and proliferation and migration of grafted human mesenchymal stem cells (hMSCs) in mice. Methods:Firefly-Luciferase (LUC) -Lentivirus vector were constructed and co-cultured with hMSCs in vitro. Then transfected hMSCs were subcutaneously injected into mice. Either in vitro and in vivo biophotonic imaging of hMSCs were detected by using Xenogen Visible System. Results:1. When multiplicity of infection (MOI) was 100,transfection efficiency of LUC-lentivirus vector could come to (29. 6 ±1. 5)%. Transfected- hMSCs had expressed LUC after 20 successive generation. Indicating this reconstructed lentivirus-LUC-vector has the characteristics of high transfection sensitivity to hMSCs,and high stability for exogenous reporter gene integration and its expression. 2. No morphological and proliferation effect on hMSCs were observed after co- culture with constructed lentivirus vector for 20 generation. This demonstrating that neither lentivirus vector nor exogenous reporter gene has cytotoxicity to targeting cells. 3. Detected in vivo bioluminescence intensity was positively correlated with grafted mass of transfected-LUC hMSCs ( R2 = 0. 9826 ). 4. Since cellular transplantation,in vivo bioluminescence signal bounded injection location were detectable and the signal intensity were linear faded out until to 6th day. Means the survival,homing,proliferation and migration of Firefly-Luciferase gene transfected hMSCs can be quantitatively in vivo monitored in real time. Conclusion: Reconstructed descytotoxicityly lentivirus vector is an effective and safety tool for Firefly-Luciferase gene integrating into hMSCs. Thus by using bioluminescent tracer techniques the phenotype and potential involving homing,proliferation and migration of LUC-transfectied hMSCs can be quantitatively in vivo real-timely monitored.

[Transferrin Receptor Expression of Human Mesenchymal Stem Cells and in Vitro Tracking by Autoradiography after Transplantation in Spinal Cord].

[Transferrin Receptor Imaging for Tracing Mesenchymal Stem Cells Implanted in the Spinal Cord].

Radionuclide imaging of mesenchymal stem cells transplanted into spinal cord.

In vivo tracking of implanted stem cells using radio-labeled transferrin scintigraphy

A Study on Transfecting Green Fluorescent Protein Gene to Rat Bone Marrow Mesenchymal Stem Cells

MR Imaging of Implanted Magnetically Labeled Rat Bone Marrow Mesenchymal Stem Cells in Normal Kidney

Magnetic Resonance Imaging of Iron Oxide-Labeled Human Embryonic Stem Cell-Derived Cardiac Progenitors.

11 C-NMSP/ 18 F-FDG Micropet to Monitor Neural Stem Cell Transplantation in a Rat Model of Traumatic Brain Injury

[Magnetic Resonance Imaging of Mesenchymal Stem Cells Transplanted Intravascularly in Treatment of Acute Renal Failure:In Vivo Experiment with Rats].

Distribution and migration of mesenchymal stem cells after intravenous transplantation in rats with spinal cord injury

Tracking Observation of Cynomolgus Monkey Bone Marrow Mesenchymal Stem Cells Labeled with Feridex after Autologus Transplantation

In vivo magnetic resonance imaging of iron oxide-labeled, intravenous-injected mesenchymal stem cells in kidneys of rabbits with acute ischemic kidney injury: detection and monitoring at 1.5 T

In Vivo Monitoring of Hmscs Stem Cell by Bioluminescent Tracer in Mice

In Vivo Mri Tracking of Iron Oxide Nanoparticle-Labeled Human Mesenchymal Stem Cells in Limb Ischemia

Long-term in Vivo CT Tracking of Mesenchymal Stem Cells Labeled with Au@BSA@PLL Nanotracers

<i>In vivo</i>MRI of autologous swine Feridex-labeled mesenchymal stem cells transplantated into liver

An NIR‐II Fluorescence/Dual Bioluminescence Multiplexed Imaging for in Vivo Visualizing the Location, Survival, and Differentiation of Transplanted Stem Cells

Tracking of Transplanted Human Mesenchymal Stem Cells in Living Mice Using Near‐Infrared Ag2S Quantum Dots

Tracking Neural Progenitor Cells Transplanted into Rabbit Spinal Cord by Detection of Dopamine Receptor 2 with Positron Emission Computed Tomography

Longitudinal Magnetic Resonance Imaging Tracking of Transplanted Neural Progenitor Cells in the Spinal Cord Utilizing the Bright-Ferritin Mechanism

In vivo MR tracking of magnetically labeled mesenchymal stem cells in rabbit liver